EPISODE · May 5, 2025 · 9 MIN
AACR 2025 Recap: Immunotherapy Shifts, ctDNA Surveillance, and Breakthroughs in HER2 and AML
from Curie: Healthcare in Focus
In this post-conference episode, Mike breaks down five major stories from AACR 2025:KEYNOTE-689 trial changes the standard of care in head and neck cancerZongertinib delivers HER2-targeted efficacy with fewer side effects in lung cancerCAR NK cells show durable remission in AMLctDNA testing in CRC detects recurrence 6+ months before imagingWerner helicase inhibitor shows first-in-class potential in MSI tumorsListen in for a concise roundup of the data and why it matters.
NOW PLAYING
AACR 2025 Recap: Immunotherapy Shifts, ctDNA Surveillance, and Breakthroughs in HER2 and AML
No transcript for this episode yet
Similar Episodes
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m
Nov 12, 2025 ·35m
Oct 17, 2025 ·40m